Preclinical evaluation of anti-rheumatic drugs in a non-human primate model of arthritic disease

There is a reluctance in preclinical rheumatoid arthritis research to consider non human primates as useful disease models in translational research and for the development of anti-rheumatic drugs. This review pleads for the usage of nonhuman primates disease models to bridge the wide immunological gap between rodents and the RA patient.

Section editors:Margreet Jonker, Michel Vierboom and Bert 't Hart – Biomedical Primate Research Centre BPRC, Rijswijk, The Netherlands